Development of the modified Daily Symptom Diary (mDSD): a patient-reported outcome measure of dysphagia for eosinophilic esophagitis.

IF 2.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Elizabeth D Bacci, Christina M Charriez, Christina Slota, Mousumi Biswas, Kathleen W Wyrwich, Carla L Zema, Claudia H M C De Oliveira, Vrunda Patel, Karin S Coyne, Ikuo Hirano
{"title":"Development of the modified Daily Symptom Diary (mDSD): a patient-reported outcome measure of dysphagia for eosinophilic esophagitis.","authors":"Elizabeth D Bacci, Christina M Charriez, Christina Slota, Mousumi Biswas, Kathleen W Wyrwich, Carla L Zema, Claudia H M C De Oliveira, Vrunda Patel, Karin S Coyne, Ikuo Hirano","doi":"10.1080/03007995.2025.2533935","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Eosinophilic esophagitis (EoE) is a progressive, chronic, Type 2 inflammatory and fibrostenotic disease causing dysphagia among other symptoms. Patient-reported outcome (PRO) measures are essential for the assessment of EoE symptoms. One such PRO measure is the Daily Symptom Diary (DSD), but its content validity has not been established. This study modified the DSD based on participants' feedback and assessed the content validity of the modified DSD (mDSD).</p><p><strong>Methods: </strong>Combined qualitative concept elicitation and cognitive interviews were conducted with adolescents (12-17 years) and adults (18-75 years) with a clinician-confirmed EoE diagnosis. Participants were asked about their symptoms and impacts. They were then asked to complete the DSD/mDSD and discuss its comprehensibility, relevance, and ease-of-use.</p><p><strong>Results: </strong>Twenty-one patients (<i>n</i> = 17 adults [mean age: 33.1 years, <i>n</i> = 13 males], <i>n</i> = 4 adolescents [mean age: 15.5 years, <i>n</i> = 3 males]) participated. The most frequently mentioned EoE symptoms were food getting stuck in the throat (<i>n</i> = 21), vomiting/throwing up (<i>n</i> = 17), and difficulty swallowing (<i>n</i> = 13). Following feedback from the first four interviews, the DSD was modified to include two more items, including a separate item for food going down slowly; the mDSD was used thereafter. Participants noted that the mDSD captured their major symptoms (<i>n</i> = 20) and was clear and understandable (<i>n</i> = 20). When asked about meaningful change in symptoms, eight (40%) would consider a reduction of 1-2 days with dysphagia per 7-day period as meaningful.</p><p><strong>Conclusion: </strong>This study confirms the content validity of the mDSD. The measure captured the symptom experience of adolescents and adults with EoE and was relevant and easy to use, supporting its use in clinical research.</p>","PeriodicalId":10814,"journal":{"name":"Current Medical Research and Opinion","volume":" ","pages":"1-9"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Research and Opinion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03007995.2025.2533935","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Eosinophilic esophagitis (EoE) is a progressive, chronic, Type 2 inflammatory and fibrostenotic disease causing dysphagia among other symptoms. Patient-reported outcome (PRO) measures are essential for the assessment of EoE symptoms. One such PRO measure is the Daily Symptom Diary (DSD), but its content validity has not been established. This study modified the DSD based on participants' feedback and assessed the content validity of the modified DSD (mDSD).

Methods: Combined qualitative concept elicitation and cognitive interviews were conducted with adolescents (12-17 years) and adults (18-75 years) with a clinician-confirmed EoE diagnosis. Participants were asked about their symptoms and impacts. They were then asked to complete the DSD/mDSD and discuss its comprehensibility, relevance, and ease-of-use.

Results: Twenty-one patients (n = 17 adults [mean age: 33.1 years, n = 13 males], n = 4 adolescents [mean age: 15.5 years, n = 3 males]) participated. The most frequently mentioned EoE symptoms were food getting stuck in the throat (n = 21), vomiting/throwing up (n = 17), and difficulty swallowing (n = 13). Following feedback from the first four interviews, the DSD was modified to include two more items, including a separate item for food going down slowly; the mDSD was used thereafter. Participants noted that the mDSD captured their major symptoms (n = 20) and was clear and understandable (n = 20). When asked about meaningful change in symptoms, eight (40%) would consider a reduction of 1-2 days with dysphagia per 7-day period as meaningful.

Conclusion: This study confirms the content validity of the mDSD. The measure captured the symptom experience of adolescents and adults with EoE and was relevant and easy to use, supporting its use in clinical research.

改进的每日症状日记(mDSD)的发展:嗜酸性粒细胞性食管炎患者报告的吞咽困难的结果测量。
目的:嗜酸性粒细胞性食管炎(EoE)是一种进行性慢性2型炎症和纤维狭窄性疾病,可引起吞咽困难等症状。患者报告的预后(PRO)指标对于评估EoE症状至关重要。其中一种PRO测量方法是每日症状日记(DSD),但其内容效度尚未确定。本研究根据被试的反馈对DSD进行修改,并评估修改后的DSD (mDSD)的内容效度。方法:采用定性概念启发和认知访谈相结合的方法,对临床确诊为EoE的青少年(12-17岁)和成人(18-75岁)进行调查。参与者被问及他们的症状和影响。然后要求他们完成DSD/mDSD,并讨论其可理解性、相关性和易用性。结果:共21例患者,其中成人17例(平均年龄33.1岁,男性13例),青少年4例(平均年龄15.5岁,男性3例)。最常提到的EoE症状是食物卡在喉咙里(n = 21),呕吐/呕吐(n = 17)和吞咽困难(n = 13)。根据前四次采访的反馈,DSD进行了修改,增加了两个项目,其中一个单独的项目是关于食物缓慢下降的;之后使用了mDSD。与会者指出,mDSD记录了他们的主要症状(n = 20),并且清晰易懂(n = 20)。当被问及症状有意义的改变时,8人(40%)认为每7天减少1-2天的吞咽困难是有意义的。结论:本研究证实了mDSD的内容效度。该方法捕获了青少年和成人EoE的症状经历,具有相关性和易用性,支持其在临床研究中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Medical Research and Opinion
Current Medical Research and Opinion 医学-医学:内科
CiteScore
4.40
自引率
4.30%
发文量
247
审稿时长
3-8 weeks
期刊介绍: Current Medical Research and Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信